Integrative analysis of rewired central metabolism in temozolomide resistant cells
Highlights: • Temozolomide (TMZ) resistant Neurospheroids (NSP) identified in U87MG cell line. • NSP shows varied dose response, two fold higher IC{sub 50} and 30% lower growth rate. • Altered Glucose and Glutamine uptake in U87MG and NSP shapes metabolic dynamics. • Differential mRNA levels of CAN genes & ABC transporters drive respiration/growth. • Integrative paradigm identifies potential metabolic drivers for TMZ resistance. An authenticated U87MG clonal glioblastoma cell line was investigated to identify a sub-population of neurospheroidal (NSP) cells within the main epithelial population (U87MG). The NSP cells sorted using Fluorescence Assisted Cell Sorting (FACS) showed varied morphology, 30% lower growth rates, 40% higher IC{sub 50} values for temozolomide drug and could differentiate into the glial cell type (NDx). Metabolite profiling using HR-LCMS identified glucose, glutamine and serine in both populations and tryptophan only in U87MG as growth limiting substrates. Glycine, alanine, glutamate and proline were secreted by U87MG, however proline and glycine were re-utilized in NSP. Exo-metabolite profiling and phenotypic microarrays identified differential metabolism of primary carbon sources glucose and derived pyruvate for U87MG; glutamine and derived glutamate metabolism in NSP. Differential mRNA abundance of AKT1, PTEN, PIK3CA controlling metabolism, drug efflux, nutrient transport and epigenetic control MDM2 are potentially critical in shaping DNA methylation effects of temozolomide. Our study provides a new insight into the combined effect of these factors leading to temozolomide resistance in NSP.